News Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston Staff September 11, 2023 Iframe sync Post navigation Previous: Major shareholder announcement – BlackRock, Inc.Next: Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration More Stories Healthcare News TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States Staff February 2, 2026 Healthcare News Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth Staff February 1, 2026 Healthcare News Patient Care AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai Staff February 1, 2026
